Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenBone Ortho has developed a CE-marked, biomimetic, wood-derived bone substitute called b.Bone. The product is designed for the treatment of trauma-induced or surgically induced bone damage, including large defects from fractures or tumors. Clinical applications include traumatology, correction of deformity, osteotomy, joint revision, and more. The technology mimics natural human bone structure using a proprietary process that transforms rattan wood into hydroxyapatite-based scaffolds with regenerative properties. The company’s products are available in several shapes and sizes to address various orthopedic needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenBone Ortho.